Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients

Patients undergoing maintenance hemodialysis (MHD) are known to have impaired immunological responses to pathogens and vaccines. Their early humoral response to coronavirus disease 2019 (COVID-19) vaccines is reduced compared to that of healthy controls,[1-2] raising concerns of waning long-term immunity. Here, we report on antibody titers against severe acute respiratory syndrome coronavirus 2…

Read the full article here

Related Articles